Hiscox seeks to calm investor concerns on Covid-19 reinsurance exposures

Hiscox sought to reassure investors on its Covid-19 exposures during its first half earnings call following a 7 percent morning dip in its share price on the back of an $82mn increase in its expected losses from the pandemic.

 

Want to read this article?

 

For details on how to subscribe or for all commercial opportunities, including advertising, please contact:

Andy Stone

Sales manager

+44 (0) 77 4160 9204

andy.stone@thomsonreuters.com

    Ricky Lamey

    Business development executive

    ricky.lamey@thomsonreuters.com